Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis : an MSBase registry sub-study
Source
Multiple Sclerosis and Related Disorders - ISSN 2211-0348-106 (2026) p. 1-10
Recent advances in interventions targeting remyelination and a systematic review of remyelinating effects of approved disease‐modifying treatments for multiple sclerosis
Source
European journal of neurology - ISSN 1351-5101-32:11 (2025) p. 1-19
Cognitive functioning in multiple sclerosis with focus on brainstem volume
Source
Acta neurologica Belgica - ISSN 0300-9009- (2025) p. 1-10
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data
Source
npj Digital Medicine - ISSN 2398-6352-8:1 (2025) p. 1-15
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years
Source
Journal of neurology, neurosurgery and psychiatry - ISSN 0022-3050-96:12 (2025) p. 1185-1193